Halcion

Halcion is a prescription medication whose active ingredient is triazolam, a benzodiazepine classified as a hypnotic. It is supplied as an oral tablet, with the specific strength varying by market; in the European Union the exact dosage form is not disclosed in this summary. Triazolam works by enhancing the activity of the neurotransmitter GABA at the GABA‑A receptor, producing sedative and anxiolytic effects in patients.

Halcion (triazolam) is indicated for short‑term management of certain sleep and anxiety disorders.

- Short‑term treatment of insomnia, particularly difficulty falling asleep. - Management of transient anxiety episodes, such as pre‑procedural nervousness. - Use as a hypnotic adjunct in patients requiring rapid onset of sleep. - May be prescribed for adjustment of sleep patterns in shift‑work or jet‑lag situations under medical supervision. - Short courses (typically ≤2 weeks) to minimize dependence risk. - Occasionally employed in diagnostic sleep studies to facilitate patient compliance.

The side‑effect profile of triazolam reflects its benzodiazepine class and varies with dose and duration.

Common: - Drowsiness or fatigue. - Dizziness or light‑headedness. - Impaired coordination or balance. - Memory disturbances, especially anterograde amnesia. - Headache. - Gastrointestinal discomfort such as nausea. - Visual disturbances or blurred vision. - Dry mouth.

Serious: - Respiratory depression, particularly when combined with other depressants. - Severe allergic reactions (rash, swelling, difficulty breathing). - Paradoxical reactions like agitation, aggression, or hallucinations. - Dependence, withdrawal symptoms, or rebound insomnia after abrupt discontinuation. - Mood changes including depression or suicidal thoughts. - Seizures.

When prescribing triazolam, clinicians consider several safety precautions to reduce the risk of adverse outcomes.

- Limit use to the shortest effective period, generally no longer than two weeks. - Assess patient history for substance abuse, dependence, or previous benzodiazepine reactions. - Use caution in individuals with respiratory disorders such as COPD or sleep apnea. - Avoid prescribing to pregnant or breastfeeding women unless benefits clearly outweigh risks. - Monitor elderly patients closely due to increased sensitivity and fall risk. - Evaluate liver or kidney impairment, as it may affect drug clearance.

Triazolam can interact with other medications, altering its sedative effect or increasing toxicity.

Avoid: - Other central nervous system depressants (e.g., alcohol, opioids, barbiturates). - Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, or ritonavir. - Antidepressants that lower seizure threshold (e.g., bupropion).

Use with caution: - Sedating antihistamines or other antihistamines. - Certain antiepileptic drugs (e.g., carbamazepine, phenytoin) that may reduce triazolam levels. - Oral contraceptives, which can increase triazolam concentrations.